Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program (NCT06236100)
Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program: A Hybrid Type 1 Effectiveness-Implementation Trial
🩺 Plain-English Summary (8th-Grade Level)
Primary Objective: Conduct a rigorous evaluation of a prevention-based intervention designed to mitigate the harms of adverse childhood experiences (ACEs) exposure and prevent future ACEs, substance use, and overdose within 36 communities experiencing a disproportionate burden of substance use and ACEs. The study has three aims: (1) use a cluster randomized controlled trial to test effectiveness of the Strengthening Families Program (SFP) + Family Advocate (FA) intervention on substance use, overdose, and ACEs in 18 communities compared with SFP-only in 18 communities; (2) conduct a robust process evaluation informed by the Consolidated Framework for Implementation Research (CFIR) to explore implementation barriers and facilitators; and (3) conduct a cost evaluation to accurately estimate the costs required to implement SFP and SFP+FA and assess the cost-effectiveness of SFP+FA relative to SFP alone. Findings will provide a roadmap about the best ways to help disproportionately affected communities prevent substance use, overdose, and ACEs.
Who can join: Review the eligibility criteria below.
Location: New Jersey Prevention Network — Tinton Falls, New Jersey
Age range: 7 Years
🧪 Interventions in This Study
- Strengthening Families Program + Family Advocate (BEHAVIORAL)
- Strengthening Families Program (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- New Jersey Prevention Network — Tinton Falls, New Jersey
📞 Contact the Study Coordinator
Phone: (908) 433-2064
Email: Andrea@njpn.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance-Related Disorders
- Impact of Work Activity on SUD Outcomes — West Haven, Connecticut
- Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions — Eugene, Oregon
- The Road to Recovery Initiative (R2RI) — Vancouver, British Columbia
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder — Richmond, Virginia
- Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment — Albuquerque, New Mexico
Explore by condition: All Substance-Related Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.